One catalyst happened a couple of weeks ago, when Merck's stock popped by nearly 4% on encouraging clinical data. Let's look ...

Investors are currently so focused on one type of drug that even good companies are being left on the sidelines.

Federal regulators have begun a safety review of two RSV medicines used to protect infants, even though no safety problems ...

BridgeBio Oncology Therapeutics (BBOT) targets KRAS and PI3Ka malignancies with next-generation small molecule therapeutics, ...

FDA turns up the heat: Federal regulators are requesting more safety information from drugmakers on products meant to protect ...

The drugs are essentially laboratory-made versions of natural antibodies that help the immune system fight off RSV. The FDA ...

Findings from a phase 3 study provided additional evidence that the first pneumococcal vaccine made specifically for adults ...

When Nicole Stovall stepped into her new role as Chief Diversity Officer at Merck, it wasn’t just another career milestone—it was the manifestation of years of purpose, persistence, and faith […] ...

The Rotary Club of Thomasville inducted its newest members on Thursday afternoon, welcoming Korey Taylor, Kellie Merck, and ...

Top-notch biotech stock Immunome rocketed Monday after the company's treatment for desmoid tumors appeared to top an approved ...

Teva Pharmaceutical is a leader in generic drugs, but these struggling makers of branded drugs may be a better choice.

Merck Foundation Chairman & Chief Executive Officer (CEO) and the First Lady of Zimbabwe Celebrate 7 Years of Long-Term ...